M. E. Garza
About
M.E. Garza is the Co-Founder of BiomedReports.com. A two-time Emmy nominated television producer and entrepreneur, Garza's background in media, writing, marketing and public affairs has allowed him to lead and establish various companies in the broadband, entertainment and communications field. He resides in Los Angeles and his passion is tracking the latest advances in biotechnology- which gives him "great hope and promise" for the future of mankind.
He is a constant student of the market who believes that the biotech sector is completely unique and dynamic sector- where everything from research to financial models and the rules for market analysis from other sectors just don't apply. He hopes to help guide BioMedReports into a leading publication that will help investors realize the potential of this revolution in finance and science, while shining the spotlight on companies that are attempting to change our lives in so many beneficial ways. |
- http://www.biomedreports.com
Website
Last 50 Posts by M. E. Garza:
-
»Exelixis Prepares for ASCO 2013, Stock Stays Rangebound
23 May 2013 in Biotech
-
»Omeros Announces INDA for OMS824 Cleared by FDA; Celgene Announces FDA Grants Priority Review for ABRAXANE
23 May 2013 in Biotech
-
»Healthcare Review: Apricus Biosciences, MannKind Corporation, Elan Corporation, Rexahn Pharmaceuticals, Breezer Ventures
23 May 2013 in Biotech
-
»Amarin Stays Rangebound, Prescriptions Stagnate
23 May 2013 in Biotech
-
»Vivus Heats Up, Shorts Discouraged on Possible Bidding War
23 May 2013 in Biotech
-
»Sentiment Drives MannKind to Fresh Highs Ahead of Vital Catalyst
23 May 2013 in Biotech
-
»Boston Scientific Announces Results from Promus Premier; Salix’s Budesonide Foam Shows Significant Results
22 May 2013 in Biotech
-
»Synergy Is A Straightforward Opportunity: Trial Results At DDW Back Plecanatide
22 May 2013 in Biotech
-
»Healthcare Review: MannKind Corporation, NPS Pharmaceuticals, Ariad Pharmaceuticals, Bristol Myers Squibb, Celsion Corporation
22 May 2013 in Biotech
-
»CytRx Offers Initial Results from Aldoxorubicin Trial; Abbott Announces CE Mark for World’s Longest Coronary Drug Eluting Stent
21 May 2013 in Biotech
-
»Healthcare Review: AcelRx Pharmaceuticals, Medtronic, Cubist Pharmaceuticals, BioScrip Inc, Orexigen Therapeutics
21 May 2013 in Biotech
-
»2 BioPharma Catalyst Trades With One Strong Acquisition Target Rumored To Be In Play
15 May 2013 in Biotech
-
»Seattle Genetics Announces ADCETRIS BLA Accepted for Filing by the FDA; Ligand Partner Rib-X Initiates Phase 3 Trial of Delafloxacin IV
14 May 2013 in Biotech
-
»Healthcare Review: TearLab Corp, Insmed Incorporated, Inovio Pharmaceuticals, Edwards Lifesciences, Arena Pharmaceuticals
14 May 2013 in Biotech
-
»Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Rally Insmed
14 May 2013 in Biotech
-
»BSD Medical Announces BSD-2000 Marketing Approval Submission; FDA Accepts Biogen’s Biologics License Application For VIII Therapy
13 May 2013 in Biotech
-
»Healthcare Review: Pharmacyclics, Alimera Sciences, Endo Health Solutions, Sequenom, Dyax Corp.
13 May 2013 in Biotech
-
»Amarin Reports Solid Vascepa TRx Growth, Stock Holds Its Ground
13 May 2013 in Biotech
-
»Genomic Health Announces Medicare Expanded Coverage Policy for Oncotype DX®; Glaxo, Theravance Confirm BREO ELLIPTA Gained US FDA Approval for Treatment of COPD
10 May 2013 in Biotech
-
»Healthcare Review: Sirona Dental Systems, Rosetta Genomics, Optimer Pharmaceuticals, Repros Therapeutics, Progenics Pharmaceuticals
10 May 2013 in Biotech
-
»Actavis Confirms District Court Ruling In Generic Lialda Patent Suit; Vermillion Announces Equity Financing
09 May 2013 in Biotech
-
»Healthcare Review: XOMA Corp, Dendreon Corporation, Orthofix International, Support.com, OraSure Technologies
09 May 2013 in Biotech
-
»Dendreon Shocks Market With PROVENGE Sales Decline In Q1 2013
09 May 2013 in Biotech
-
»Sarepta Therapeutics: Notes on Q1 2013
09 May 2013 in Biotech
-
»Nuvilex Is Features Stock of the Month of May
09 May 2013 in Biotech
-
»Merck Announces FDA Acceptance of BLA for Investigational Allergy Tablet; CytRx Provides Update on Clinical Programs
08 May 2013 in Biotech
-
»Healthcare Review: Genomic Health, Arena Pharmaceuticals, Biodel Inc, Alexza Pharmaceuticals, VIVUS
08 May 2013 in Biotech
-
»Imprimis Rising: Unique Pathway Requires Fewer and Smaller Clinical Trials (Updated)
08 May 2013 in Biotech
-
»Pluristem Carving Out Distinct Niche in Orthopedic Medicine with New Clinical Trials in Rotator Cuff Repair
08 May 2013 in Biotech
-
»Anthera Announces Additional Data from Phase 2b PEARL-SC; pSivida Announces Commercial Launch of ILUVIEN
07 May 2013 in Biotech
-
»Healthcare Review: Insulet Corporation, Immunomedics, Ariad Pharmaceuticals, Hologic, Santarus
07 May 2013 in Biotech
-
»Celgene’s Revlimid Approaches FDA Decision For MCL Indication
07 May 2013 in Biotech
-
»Tauriga Sciences’ CEO Pulls Off Impressive Turnaround; More to Come?
07 May 2013 in Biotech
-
»CytRx Receives Recommendation for Aldoxorubicin; Celgene’s Apremilast Achieves Statistical Significant for Primary, Major Secondary Endpoints
06 May 2013 in Biotech
-
»Healthcare Review: CytRx Corporation, TrovaGene Inc, EntreMed Inc, CombiMatrix Corporation, Humana Inc
06 May 2013 in Biotech
-
»Arena & VIVUS Weaken On Poor Obesity Drug Prospects In Europe
06 May 2013 in Biotech
-
»Ambrx and Bristol-Myers Squibb Collaborate on Discovery; Bristol-Myers Squibb Receives US FDA sNDA Approval for SUSTIVA
03 May 2013 in Biotech
-
»Healthcare Review: Delcath Systems, Chemed Corporation, Regeneron Pharmaceuticals, Arena Pharmaceuticals, Genetic Technologies
03 May 2013 in Biotech
-
»3 Disastrous Outcomes This Week for Titan, AVEO, and Delcath
03 May 2013 in Biotech
-
»Delcath Confirms FDA Panel Voted 16-0 Against Melblez Kit; AVEO, Astellas Confirm Unfavorable Vote by FDA on Tivozanib
02 May 2013 in Biotech
-
»Healthcare Review: Hyperion Therapeutics, Gilead Sciences, Cardinal Health, ACADIA Pharmaceuticals, Questcor Pharmaceuticals
02 May 2013 in Biotech
-
»Post-IPO Strength Seen In Stemline Therapeutics
02 May 2013 in Biotech
-
»Shire’s Vyvanse Approved in US; Raptor’s PROCYSBI Receives FDA Approval
01 May 2013 in Biotech
-
»Healthcare Review: Allergan, ACADIA Pharmaceuticals, AVEO Pharmaceuticals, Humana Inc, Regeneron Pharmaceuticals
01 May 2013 in Biotech
-
»FDA Rejects Titan Pharma’s Opioid Addiction Implant Probuphine
01 May 2013 in Biotech
-
»Delcath Says FDA Posted Briefing Documents Ahead of ODAC Meeting; FDA: Morning-After Pill to Move Over-the-Counter
30 Apr 2013 in Biotech
-
»Healthcare Review: AVEO Pharmaceuticals, Delcath Systems, ACADIA Pharmaceuticals, Aetna Inc, Durect Corporation
30 Apr 2013 in Biotech
-
»Galectin Therapeutics Gets A Bid After Promising Results
30 Apr 2013 in Biotech
-
»Merck, Pfizer Announce Worldwide Collaboration Deal for Ertugliflozin; Gilead Receives CRL from FDA for Elvitegravir, Cobicistat
29 Apr 2013 in Biotech
-
»Healthcare Review: Auxilium Pharmaceuticals, Conceptus, Tenet Healthcare Corp, HCA Holdings Inc, Express Scripts Holding
29 Apr 2013 in Biotech


